mRNA-3630

N/A

Report date: 2025/11/19 10:17:03
NME

Base Information

Drug NamemRNA-3630
Drug Alias NameHuman alpha-galactosidase A mRNA therapy (Moderna Therapeutics/Medical College of Wisconsin)systemic human alpha-galactosidase A mRNA therapy (Moderna Therapeutics/Medical College of Wisconsin)mRNA-3630
ClassificationCell and gene therapy > Gene therapy > mRNA
Mechanisms of Actionα-Galactosidase stimulants
Targetsα-Galactosidase
Therapy Area/IndicationsFabry Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesModerna Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesModerna IncThe Medical College Of Wisconsin Nonprofit
Active IndicationsN/A
Inactive IndicationsFabry Disease

Other Information

ATC CodeN/A
Related LinksN/A